FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311753475> ?p ?o ?g. }

• W4311753475 abstract "Abstract Background Ibrutinib is a Bruton tyrosine kinase inhibitor, approved in the last few years for treatment as primary option for all subsets of chronic lymphocytic leukemia (CLL). Its use is associated with increased incidence of atrial fibrillation (AF). Objectives Aim of this study is to determine whether there are echocardiographic parameters that could identify patients at major risk of developing ibrutinib-related atrial fibrillation (IRAF). Methods We performed a retrospective review of 26 patients (mean age 70,34 ± 11,69; 27% females), admitted at our EchoLab in the last year, who underwent echocardiogram prior to Ibrutinib treatment. Echo-Doppler assessment was realized according to the standards of the European Association of Cardiovascular Imaging (EACVI) standardization of the echo report. Left atrial (LA) strain was measured with EchoPAC, obtaining peak atrial longitudinal strain (PALS) and peak atrial contraction strain (PACS) on 4-chambers and 2-chambers views. Continuous normally distributed variables were compared by using the Student t-test. A probability value &lt; 0,05 was considered statistically significant. Analyses were performed with SPSS version 25 (IBM Corporation, Somers, New York). Results Six patients developed IRAF (23%). There weren't differences of clinical characteristics between the two groups (age, body mass index, arterial blood pressure, heart rate and diabetes, hypertension and cardiovascular diseases prevalence). It was noticed that IRAF's group had lower ejection fraction (EF) (54,67 ± 1,96 vs 60,90 ± 4,35, p-value &lt; 0,0001), higher left atrium volume index (48,95 ± 16,31 vs 34,18 ± 9,07, p-value: 0,009), higher pulmonary arterial pressure values (PAPs) (44,16 ± 11,26 vs 32,89 ± 8,44, p-value: 0,015). Furthermore, it was noticed that peak atrial longitudinal strain (PALS) and peak atrial contraction strain (PACS) were reduced in patients who developed IRAF (PALS 4Ch: 18,89 ± 6,90 vs 29,40 ± 9,79, p-value 0,06; PACS 4Ch: 10,56 ± 5,66 vs 14,31 ± 5,72, p-value: 0,25; PALS 2Ch: 23,36 ± 5,02 vs 32,88 ± 16,57, p-value: 0,28; PACS 2Ch: 13,61 ± 8,16 vs 18,33 ± 9,87, p-value: 0,39), but not statistically significant, probably due to the sample size. Conclusions This is a preliminary pilot study which confirms the data already present in the literature. The importance of baseline evaluation by echocardiogram including measurement of atrial strain of patients before starting treatment with Ibrutinib is emphasized since, given the same anthropometric characteristics and risk factors, there are echocardiographic parameters that help us to identify patients at major risk of developing IRAF. Pharmacological intervention tailored on this type of basal echocardiographic evaluation could allow the reduction of IRAF's onset and improve patient outcomes in the long term. Certainly, further follow-up studies will be needed to confirm this hypothesis." @default.
• W4311753475 created "2022-12-28" @default.
• W4311753475 creator A5000931685 @default.
• W4311753475 creator A5002438030 @default.
• W4311753475 creator A5005922904 @default.
• W4311753475 creator A5013028293 @default.
• W4311753475 creator A5044347105 @default.
• W4311753475 creator A5045162853 @default.
• W4311753475 creator A5048843657 @default.
• W4311753475 creator A5051622750 @default.
• W4311753475 creator A5067992701 @default.
• W4311753475 creator A5071573098 @default.
• W4311753475 date "2022-12-14" @default.
• W4311753475 modified "2023-10-16" @default.
• W4311753475 title "563 THE ROLE OF ECHOCARDIOGRAPHY FOR MANAGEMENT OF IBRUTINIB RELATED ATRIAL FIBRILLATION: ONE MORE SUPPORT OVER CLINICAL EVALUATION" @default.
• W4311753475 doi "https://doi.org/10.1093/eurheartjsupp/suac121.120" @default.
• W4311753475 hasPublicationYear "2022" @default.
• W4311753475 type Work @default.
• W4311753475 citedByCount "0" @default.
• W4311753475 crossrefType "journal-article" @default.
• W4311753475 hasAuthorship W4311753475A5000931685 @default.
• W4311753475 hasAuthorship W4311753475A5002438030 @default.
• W4311753475 hasAuthorship W4311753475A5005922904 @default.
• W4311753475 hasAuthorship W4311753475A5013028293 @default.
• W4311753475 hasAuthorship W4311753475A5044347105 @default.
• W4311753475 hasAuthorship W4311753475A5045162853 @default.
• W4311753475 hasAuthorship W4311753475A5048843657 @default.
• W4311753475 hasAuthorship W4311753475A5051622750 @default.
• W4311753475 hasAuthorship W4311753475A5067992701 @default.
• W4311753475 hasAuthorship W4311753475A5071573098 @default.
• W4311753475 hasBestOaLocation W43117534751 @default.
• W4311753475 hasConcept C126322002 @default.
• W4311753475 hasConcept C164705383 @default.
• W4311753475 hasConcept C2777938653 @default.
• W4311753475 hasConcept C2778198053 @default.
• W4311753475 hasConcept C2778461978 @default.
• W4311753475 hasConcept C2779161974 @default.
• W4311753475 hasConcept C2779878957 @default.
• W4311753475 hasConcept C71924100 @default.
• W4311753475 hasConcept C78085059 @default.
• W4311753475 hasConceptScore W4311753475C126322002 @default.
• W4311753475 hasConceptScore W4311753475C164705383 @default.
• W4311753475 hasConceptScore W4311753475C2777938653 @default.
• W4311753475 hasConceptScore W4311753475C2778198053 @default.
• W4311753475 hasConceptScore W4311753475C2778461978 @default.
• W4311753475 hasConceptScore W4311753475C2779161974 @default.
• W4311753475 hasConceptScore W4311753475C2779878957 @default.
• W4311753475 hasConceptScore W4311753475C71924100 @default.
• W4311753475 hasConceptScore W4311753475C78085059 @default.
• W4311753475 hasIssue "Supplement_K" @default.
• W4311753475 hasLocation W43117534751 @default.
• W4311753475 hasOpenAccess W4311753475 @default.
• W4311753475 hasPrimaryLocation W43117534751 @default.
• W4311753475 hasRelatedWork W2096784960 @default.
• W4311753475 hasRelatedWork W2248649580 @default.
• W4311753475 hasRelatedWork W2348720246 @default.
• W4311753475 hasRelatedWork W2364196197 @default.
• W4311753475 hasRelatedWork W2885044340 @default.
• W4311753475 hasRelatedWork W2945739103 @default.
• W4311753475 hasRelatedWork W2982010161 @default.
• W4311753475 hasRelatedWork W3029306217 @default.
• W4311753475 hasRelatedWork W3041651780 @default.
• W4311753475 hasRelatedWork W4308053554 @default.
• W4311753475 hasVolume "24" @default.
• W4311753475 isParatext "false" @default.
• W4311753475 isRetracted "false" @default.
• W4311753475 workType "article" @default.